How Temasek unlocked value at Sembcorp

Temasek's efforts to support its Singapore-listed holdings in the face of Covid-19 could enliven the local market

Ben Paul

Published Sun, Sep 13, 2020 · 09:50 PM

WHEN Temasek Holdings reports its annual performance, it isn't its total return or the views of its top executives about the global economy that I find most interesting.

Instead, it is the seemingly unending list of up-and-coming companies around the world in which Temasek has invested that really arouses my curiosity.

The names of these companies are reeled off in Temasek's press releases almost in passing. Yet, many of them are involved in very exciting segments of the technology and life sciences fields, and have fascinating stories of their own.

Among the companies mentioned in Temasek's latest annual review last week was Beam Therapeutics, a small biotechnology company that is developing…